Completed

Potlako: A Programmatic Multi-facility Level Intervention to Improve Access to Timely Oncology Care in Botswana

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Potlako intervention

Other
Who is being recruted

Neoplasms

Over 18 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Services Research Study

Interventional
Study Start: May 2016
See protocol details

Summary

Principal SponsorHarvard School of Public Health (HSPH)
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 13, 2016

Actual date on which the first participant was enrolled.

Diagnostic and treatment delays contribute substantially to disparities in cancer morbidity and mortality between low- and middle- income countries (LMICs) and high-income countries. Individuals present with advanced stage disease resulting in minimal chance for cure or long-term survival. The Potlako project will implement and evaluate a multifaceted intervention to test the hypothesis that a package of enhanced coordination of care including an electronic messaging, transportation support, and training targeted at generalist clinicians at primary and secondary level facilities, can reduce time to diagnosis and stage at diagnosis for HIV-infected individuals with cancer.

Official TitlePotlako: A Programmatic Multi-facility Level Intervention to Improve Access to Timely Oncology Care in Botswana
NCT02752061
Principal SponsorHarvard School of Public Health (HSPH)
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

979 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Services Research Study

These studies look at how healthcare is delivered, managed, and organized. They aim to improve care quality, patient experience, and access to treatment.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Neoplasms

Criteria

2 inclusion criteria required to participate
Citizen of Botswana
Suspected or diagnosed cancer
1 exclusion criteria prevent from participating
Involuntary incarceration

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Patient presenting with possible cancer symptoms/sign to a clinic or hospital in Kweneng East District during study period.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Botswana Harvard AIDS Institute

Gaborone, BotswanaOpen Botswana Harvard AIDS Institute in Google Maps
CompletedOne Study Center